X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/11/25/2562660/0/en/Saniona-AB-s-Nomination-Committee-for-the-Annual-General-Meeting-2023.html
https://www.globenewswire.com/news-release/2022/11/03/2547248/0/en/Saniona-s-anti-inflammatory-and-anti-fibrotic-candidate-SAN903-is-ready-for-clinical-studies.html
https://www.globenewswire.com/news-release/2022/09/30/2525839/0/en/Saniona-extends-runway-and-amends-loan-agreement-with-Formue-Nord.html
https://www.globenewswire.com/news-release/2022/08/25/2504266/0/en/Saniona-publishes-its-interim-report-for-the-second-quarter-of-2022.html
https://www.globenewswire.com/news-release/2022/08/18/2501050/0/en/Bulletin-from-the-Saniona-AB-extraordinary-general-meeting-on-August-18-2022.html
https://www.globenewswire.com/news-release/2022/08/05/2492965/0/en/Saniona-provides-update-on-outstanding-option-programs.html
https://www.globenewswire.com/news-release/2022/07/15/2480506/0/en/Notice-of-extraordinary-general-meeting-in-Saniona-AB.html
https://www.globenewswire.com/news-release/2022/07/06/2474536/0/en/Saniona-CEO-Thomas-Feldthus-and-board-member-Carl-Johan-Sundberg-purchase-Saniona-shares-in-the-open-market.html
https://www.globenewswire.com/news-release/2022/06/30/2472284/0/en/Saniona-reports-positive-top-line-results-from-the-SAN711-Phase-1-Clinical-Trial.html
https://www.globenewswire.com/news-release/2022/06/24/2468545/0/en/Saniona-s-preclinical-candidate-SAN903-shows-robust-dampening-of-fibrosis-in-Chronic-Kidney-Disease-model.html
Market Place
Share 
